Home    Back

Bone marrow transplant    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
274Osteogenesis Imperfecta2

274. Osteogenesis Imperfecta    [ 78 clinical trials,   87 drugs,   (DrugBank: 19 drugs),   14 drug target genes,   74 drug target pathways]
Searched query = "Osteogenesis Imperfecta"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 78 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00187018
(ClinicalTrials.gov)		March 200412/9/2005Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot StudyMarrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot StudyOsteogenesis ImperfectaBiological: Bone marrow transplantSt. Jude Children's Research HospitalNULLCompletedN/AN/ABoth9N/AUnited States
2NCT00705120
(ClinicalTrials.gov)		November 199523/6/2008Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow TransplantationTreatment of Severe (Types II and III) Osteogenesis Imperfecta by Allogeneic Bone Marrow TransplantationOsteogenesis ImperfectaOther: Bone Marrow Cell Transplantation;Radiation: Irradiation, Total Body;Drug: Cyclophosphamide;Drug: Cyclosporin;Procedure: Mesenchymal Stem Cell Transplantation;Drug: BusulfanSt. Jude Children's Research HospitalNULLCompleted3 YearsN/ABoth9Phase 1United States